Diagnostic accuracy of a molecular drug susceptibility testing method for the antituberculosis drug ethambutol: A systematic review and meta-analysis

Journal of Clinical Microbiology

Volumn 52, Issue 8, 2014, Pages 2913-2924

  Cheng, Song ^a   Cui, Zhenling ^a   Li, Yuanyuan ^a,b   Hu, Zhongyi ^a  

^a TONGJI UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; EMBB PROTEIN, MYCOBACTERIUM TUBERCULOSIS; GLYCOSYLTRANSFERASE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIUM DETECTION; CODON; DNA SEQUENCE; EMBB GENE; MEASUREMENT ACCURACY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PYROSEQUENCING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SENSITIVITY AND SPECIFICITY; DRUG EFFECTS; EVALUATION STUDY; GENETICS; HUMAN; META ANALYSIS; MICROBIAL SENSITIVITY TEST; MOLECULAR DIAGNOSIS; PROCEDURES;

ANTITUBERCULAR AGENTS; ETHAMBUTOL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; PENTOSYLTRANSFERASES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 84905247512     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00560-14     Document Type: Review

References (56)

1. World Health Organization. 2013. Global tuberculosis report 2013. WHO/HTM/TB/2013.11. World Health Organization, Geneva, Switzerland.
2. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder HL, Binkin N, Dye C, Williams R, Raviglione MC. 2001. Global trends in resistance to antituberculosis drugs. N. Engl. J. Med. 344:1294-1303. http://dx.doi.org/10.1056/NEJM200104263441706. (Pubitemid 32377203)
3. World Health Organization. 2011. Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. WHO/HTM/TB/2011.6. World Health Organization, Geneva, Switzerland.
4. Donald PR, Maher D, Maritz JS, Qazi S. 2006. Ethambutol dosage for the treatment of children: literature review and recommendations. Int. J. Tuberc. Lung Dis. 10:1318-1330. (Pubitemid 44929444)
5. Wu MH, Chiang CY, Deng YM, Wang TF, Jou R. 2013. Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan, 2007-2011. Int. J. Tuberc. Lung Dis. 17:113-119. http://dx.doi.org/10.5588/ijtld.12.0521.
6. Sangare L, Diande S, Kouanda S, Dingtoumda BI, Mourfou A, Ouedraogo F, Sawadogo I, Nebie B, Gueye A, Sawadogo LT, Traore AS. 2010. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso. Ann. Afr. Med. 9:15-19. http://dx.doi.org/10.4103/1596-3519.62619.
7. Sangaré L, Diandé S, Badoum G, Dingtoumda B, Traoré AS. 2010. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso. Int. J. Tuberc. Lung Dis. 14:1424-1429.
8. Ministry of Health of the People's Republic of China. 2010. National TB drug resistance baseline survey report (2007-2008). People's Medical Publishing House, Ltd, Beijing, China.
9. Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopeć E, Zwolska Z, Kirikae F, Toyota E, Kobayashi I, Morita K, Kudo K, Kato S, Kuratsuji T, Mori T, Kirikae T. 2007. Detection of multidrug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 45:179-192. http://dx.doi.org/10.1128/JCM. 00750-06. (Pubitemid 46106425)
10. Moher D, Liberati A, Tetzlaff J, Altman DG. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PrismA statement. J. Clin. Epidemiol. 62:1006-1012. http://dx.doi.org/10.1016/j.jclinepi.2009.06.005.
11. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. 2011. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 155:529-536. http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00009.
12. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. 2006. Meta-Disc: a software for meta-analysis of test accuracy data. BMC Med. Res. Methodol. 6:31. http://dx.doi.org/10.1186/1471-2288-6-31.
13. Irwig L, Macaskill P, Glasziou P, Fahey M. 1995. Meta-analytic methods for diagnostic test accuracy. J. Clin. Epidemiol. 48:119-130. http://dx.doi.org/10.1016/0895-4356(94)00099-C.
14. Moses LE, Shapiro D, Littenberg B. 1993. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat. Med. 12:1293-1316. http://dx.doi.org/10.1002/ sim.4780121403. (Pubitemid 23230833)
15. Escalante P, Ramaswamy S, Sanabria H, Soini H, Pan X, Valiente-Castillo O, Musser JM. 1998. Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. Tuberc. Lung Dis. 79:111-118. http://dx.doi.org/10.1054/tuld.1998.0013.
16. Lee AS, Othman SN, Ho YM, Wong SY. 2004. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48:4447-4449. http://dx.doi.org/10.1128/AAC.48.11. 4447-4449.2004. (Pubitemid 39434913)
17. Ramaswamy SV, Dou SJ, Rendon A, Yang Z, Cave MD, Graviss EA. 2004. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis Isolates from Monterrey, Mexico. J. Med. Microbiol. 53:107-113. http://dx.doi.org/10. 1099/jmm.0.05343-0. (Pubitemid 38223688)
18. Zhang SL, Qi H, Qiu DL, Li DX, Zhang J, Du CM, Wang GB, Yang ZR, Sun Q. 2007. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates recovered from central China. Biochem. Genet. 45:281-290. http://dx.doi.org/10.1007/s10528-006-9074-6. (Pubitemid 46466217)
19. Guo JH, Xiang WL, Zhao QR, Luo T, Huang M, Zhang J, Zhao J, Yang ZR, Sun Q. 2008. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Sichuan province in China. Jpn. J. Infect. Dis. 61:264-268.
20. Jadaun GP, Das R, Upadhyay P, Chauhan DS, Sharma VD, Katoch VM. 2009. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India. Int. J. Antimicrob. Agents 33:483-486. http://dx.doi.org/10.1016/j.ijantimicag.2008.10.017.
21. Perdigão J, Macedo R, Ribeiro A, Brum L, Portugal I. 2009. Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations. Int. J. Antimicrob. Agents 33:334-338. http://dx.doi.org/10.1016/j.ijantimicag. 2008.09.021.
22. Plinke C, Cox HS, Kalon S, Doshetov D, Rüsch-Gerdes S, Niemann S. 2009. Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results. Tuberculosis (Edinb.) 89:448-452. http://dx.doi.org/10. 1016/j.tube.2009.09.001.
23. Hillemann D, Rüsch-Gerdes S, Richter E. 2009. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 47:1767-1672. http://dx.doi.org/10.1128/JCM. 00081-09.
24. Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. 2010. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 48:1683-1689. http://dx.doi.org/10.1128/JCM.01947- 09.
25. Hu Y, Hoffner S, Jiang W, Wang W, Xu B. 2010. Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: a population-based study. Int. J. Tuberc. Lung Dis. 14:210-216.
26. Shi D, Li L, Zhao Y, Jia Q, Li H, Coulter C, Jin Q, Zhu G. 2011. Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China. J. Antimicrob. Chemother. 66:2240-2247. http://dx.doi.org/10.1093/jac/dkr284.
27. Huang WL, Chi TL, Wu MH, Jou R. 2011. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 49:2502-2508. http://dx.doi.org/10.1128/JCM.00197-11.
28. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE. 2012. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 55:2032-2041.
29. Miotto P, Cabibbe AM, Mantegani P, Borroni E, Fattorini L, Tortoli E, Migliori GB, Cirillo DM. 2012. GenoType MTBDRsl performance on clinical samples with diverse genetic background. Eur. Respir. J. 40:690-698. http://dx.doi.org/10.1183/09031936.00164111.
30. Kiet VS, Lan NT, An DD, Dung NH, Hoa DV, van Vinh Chau N, Chinh NT, Farrar J, Caws M. 2010. Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 48:2934-2939. http://dx.doi.org/10.1128/JCM.00201-10.
31. Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM. 2012. Evaluation of the GenoType MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs. Int. J. Tuberc. Lung Dis. 16:104-109. http://dx.doi.org/10.5588/ijtld.10.0600.
32. Živanović I, Vuković D, Dakić I, Stefanović G, Savić B. 2012. Detection of drug-resistant Mycobacterium tuberculosis strains isolated in Serbia by the GenoType MTBDRsl assay. Arch. Biol. Sci. 64:1311-1318. http://dx.doi.org/10.2298/ABS1204311Z.
33. Ignatyeva O, Kontsevaya I, Kovalyov A, Balabanova Y, Nikolayevskyy V, Toit K, Dragan A, Maxim D, Mironova S, Kummik T, Muntean I, Koshkarova E, Drobniewski F. 2012. Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study. J. Clin. Microbiol. 50:1593-1597. http://dx.doi.org/10.1128/ JCM.00039-12.
34. Ajbani K, Nikam C, Kazi M, Gray C, Boehme C, Balan K, Shetty A, Rodrigues C. 2012. Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides, and ethambutol on clinical sediments. PLoS One 7:e49433. http://dx.doi.org/10.1371/journal.pone.0049433.
35. Ahmad S, Itani LY, Fares E, Araj GF. 2008. Varying prevalence of embB codon 306 mutations in ethambutol-resistant clinical Mycobacterium tuberculosis Isolates from Beirut and Dubai. J. Chemother. 20:285-287. http://dx.doi.org/10. 1179/joc.2008.20.2.285. (Pubitemid 351797073)
36. Ahmad S, Jaber AA, Mokaddas E. 2007. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis (Edinb.) 87:123-129. http://dx.doi.org/10.1016/j.tube.2006.05.004. (Pubitemid 46217260)
37. Isola D, Pardini M, Varaine F, Niemann S, Rüsch-Gerdes S, Fattorini L, Orefici G, Meacci F, Trappetti C, Rinaldo Oggioni M, Orrù G; LONG-DRUG study group. 2005. A pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region. J. Microbiol. Methods 62:113-120. http://dx.doi.org/10.1016/j.mimet.2005.02.004.
38. Zhao JR, Bai YJ, Zhang QH, Wang Y, Luo M, Yan XJ. 2005. Pyrosequencing-based approach for rapid detection of rifampin-resistant Mycobacterium tuberculosis. Diagn. Microbiol. Infect. Dis. 51:135-137. http://dx.doi.org/10.1016/j.diagmicrobio.2004.10.001. (Pubitemid 40215424)
39. Engström A, Morcillo N, Imperiale B, Hoffner SE, Juréen P. 2012. Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing. J. Clin. Microbiol. 50:2026-2033. http://dx.doi.org/10.1128/JCM.06664-11.
40. Johnson R, Jordaan AM, Pretorius L, Engelke E, van der Spuy G, Kewley C, Bosman M, van Helden PD, Warren R, Victor TC. 2006. Ethambutol resistance testing by mutation detection. Int. J. Tuberc. Lung Dis. 10:68-73. (Pubitemid 43266280)
41. Shen X, Shen GM, Wu J, Gui XH, Li X, Mei J, DeRiemer K, Gao Q. 2007. Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 51:2618-2620. http://dx.doi.org/10.1128/AAC.01516-06. (Pubitemid 47047350)
42. Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29. http://dx.doi.org/10.1054/tuld.1998.0002. (Pubitemid 29050434)
43. Guo Q, Zheng RJ, Zhu CT, Zou LL, Xiu JF, Li J, Hu ZY. 2013. Meta-analysis of pyrosequencing for the rapid detection of isoniazid-resistance in Mycobacterium tuberculosis. Chin. J. Lab. Med. 4:329-332. http://dx.doi.org/10. 3760/cma.j.issn.1009-9158.2013.04.009.
44. Xu HB, Jiang RH, Sha W, Li L, Xiao HP. 2010. PCR-single-strand conformational polymorphism method for rapid detection of rifampin-resistant Mycobacterium tuberculosis: systematic review and meta-analysis. J. Clin. Microbiol. 48:3635-3640. http://dx.doi.org/10.1128/JCM.00960-10.
45. Alcaide F, Pfyffer GE, Telenti AI. 1997. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob. Agents Chemother. 41:2270-2273. (Pubitemid 27422225)
46. Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles B, Musser JM, Jacobs WR, Jr. 1997. The emb operon, a unique gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat. Med. 3:567-570. http://dx.doi.org/10.1038/nm0597-567. (Pubitemid 27198658)
47. Sreevatsan S, Stockbauer KE, Pan X, Kreiswirth BN, Moghazeh SL, Jacobs WR, Jr, Telenti A, Musser JM. 1997. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob. Agents Chemother. 41:1677-1681. (Pubitemid 27339866)
48. Lety MA, Nair S, Berche P, Escuyer V. 1997. A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 41:2629-2633. (Pubitemid 27524732)
49. Hazbón MH, Bobadilla del Valle M, Guerrero MI, Varma-Basil M, Filliol I, Cavatore M, Colangeli R, Safi H, Billman-Jacobe H, Lavender C, Fyfe J, García-García L, Davidow A, Brimacombe M, León CI, Porras T, Bose M, Chaves F, Eisenach KD, Sifuentes-Osornio J, Ponce de León A, Cave MD, Alland D. 2005. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob. Agents Chemother. 49:3794-3802. http://dx.doi.org/10.1128/AAC.49.9.3794-3802. 2005. (Pubitemid 41233034)
50. Safi H, Fleischmann RD, Peterson SN, Jones MB, Jarrahi B, Alland D. 2010. Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 54:103-108. http://dx.doi.org/10. 1128/AAC.01288-09.
51. Parsons LM, Salfinger M, Clobridge A, Dormandy J, Mirabello L, Polletta VL, Sanic A, Sinyavskiy O, Larsen SC, Driscoll J, Zickas G, Taber HW. 2005. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob. Agents Chemother. 49:2218-2225. http://dx.doi.org/10.1128/AAC.49.6.2218-2225.2005. (Pubitemid 40734448)
52. Ramaswamy SV, Amin AG, Göksel S, Stager CE, Dou SJ, El Sahly H, Moghazeh SL, Kreiswirth BN, Musser JM. 2000. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44:326-336. http://dx.doi.org/10.1128/AAC.44.2.326-336.2000. (Pubitemid 30060727)
53. Shi L, Zhou R, Liu Z, Lowary TL, Seeberger PH, Stocker BL, Crick DC, Khoo KH, Chatterjee D. 2008. Transfer of the first arabinofuranose residue to galactan is essential for Mycobacterium smegmatis viability. J. Bacteriol. 190:5248-5255. http://dx.doi.org/10.1128/JB.00028-08.
54. Madison B, Robinson-Dunn B, George I, Gross W, Lipman H, Metchock B, Sloutsky A, Washabaugh G, Mazurek G, Ridderhof J. 2002. Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods. J. Clin. Microbiol. 40:3976-3979. http://dx.doi.org/10.1128/JCM.40.11.3976-3979.2002. (Pubitemid 35285776)
55. Banu S, Rahman SM, Khan MS, Ferdous SS, Ahmed S, Gratz J, Stroup S, Pholwat S, Heysell SK, Houpt ER. 2014. Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory. J. Clin. Microbiol. 52:1561-1563. http://dx.doi.org/10.1128/JCM.02378-13.
56. Lijmer JG, Bossuyt PM, Heisterkamp SH. 2002. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat. Med. 21:1525-1537. http://dx.doi.org/10.1002/sim.1185. (Pubitemid 34746061)